We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EAT:NYSEBrinker International, Inc. Analysis

Data as of 2026-05-21 - not real-time

$131.18

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Brinker International (EAT) is trading at $131.18, well below its 20‑day ($138.81), 50‑day ($143.96) and 200‑day ($143.80) simple moving averages, with a bearish MACD histogram and an RSI of 43.1, indicating short‑term momentum weakness and a neutral‑to‑bearish technical outlook. The stock’s 30‑day volatility is high at 70.7% and beta exceeds 1.0, while volume has been trending down, suggesting heightened price sensitivity and limited buying pressure. On the valuation side, a trailing P/E of 12.8 and forward P/E of 10.5 appear modest, but a price‑to‑book of 13.86 and a discounted cash‑flow fair value of $69.65 place the current price in the overvalued range, with analysts projecting a 41.9% upside to a median target of $189.
Despite the technical frailty, the company delivered Q1 CY2026 sales up 3.2% YoY to $1.47 bn, beat non‑GAAP EPS expectations ($2.90 vs. consensus) and raised its 2026 guidance on Chili’s momentum, underpinning a “buy” consensus from 21 analysts. However, a debt‑to‑equity ratio of 430.5, negligible ROE (1.4%), and zero dividend payout raise concerns about financial leverage and capital return sustainability. The blend of modest growth, strong cash flow generation, and sector‑cyclical exposure suggests a balanced growth‑value profile, but the high leverage and valuation premium warrant caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below key moving averages and bearish MACD
  • Support level near $124.96
  • Recent earnings beat but limited upside on technicals

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Guidance raise and strong Chili’s momentum
  • Analyst consensus buy with median target $189
  • Forward P/E compression to 10.5 indicating value appeal

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio and low ROE
  • Stable franchise cash flows supporting resilience
  • Consumer‑cyclical exposure to economic cycles

Key Metrics & Analysis

Financial Health

Revenue Growth3.20%
Profit Margin8.07%
P/E Ratio12.8
ROE139.22%
ROA13.88%
Debt/Equity430.54
P/B Ratio13.9
Op. Cash Flow$757.8M
Free Cash Flow$317.6M

Technical Analysis

TrendNeutral
RSI43.1
Support$124.96
Resistance$155.04
MA 20$138.81
MA 50$143.96
MA 200$143.80
MACDBearish
VolumeDecreasing
Fear & Greed Index89.88

Valuation

Fair Value$69.65
Target Price$186.10
Upside/Downside41.86%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.08
Volatility70.72%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.